SONN 2.84 ▼ -2.07% Live Trading Data - Stocknear

Sonnet BioTherapeutics I...

NASDAQ: SONN · Real-Time Price · USD
2.84
-0.06 (-2.07%)
At close: Sep 05, 2025, 11:31 AM
-2.07%
Bid 2.81
Market Cap 19.02M
Revenue (ttm) 1M
Net Income (ttm) -13.56M
EPS (ttm) -6.82
PE Ratio (ttm) -0.42
Forward PE -0.03
Analyst Buy
Ask 2.91
Volume 221,870
Avg. Volume (20D) 4,062,287
Open 2.99
Previous Close 2.90
Day's Range 2.73 - 3.03
52-Week Range 1.08 - 19.30
Beta 1.05

About SONN

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SONN
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SONN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
+86.46%
Sonnet BioTherapeutics shares are trading higher a... Unlock content with Pro Subscription
8 months ago
-5.71%
Sonnet BioTherapeutics shares are trading higher after the company announced the highest dose of its Phase 1 SB101 trial results for SON-1010 have been formally evaluated by the safety review committee, with the maximum tolerated dose set at 1200ng/kg.